CopyMark Law Group
4.9/5
Drawing for BIFIBABY

USPTO serial 79366679

BIFIBABY

Reviewed by CopyMark Law Group

Reg. 7525581Status 700Registered
Filing date
Status date
Registration date
Oct 8, 2024
Examiner
O'BRIEN, JENNIFER LYNN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIFIBABY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle E. Tochtrop

Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC6509 Brecksville Road, #31550CLEVELAND, OH 44131-4854United States

Goods and services

ClassDescriptionStatusFirst use
001Micro-organisms and cultures of micro-organisms, in particular bacteria for use in food manufacture, bifidobacterium probiotic bacteria for use in the manufacture of food supplements, food, medical preparations, yeast nutrients for industrial purposes and fermented milk products in the nature of milk ferments for industrial purposes; micro-organisms and cultures of microorganisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and reared animal species, not for medical or veterinary use for use in the manufacture of food supplements, food, medical preparations; micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form, namely, probiotic bacteria for use in the manufacture of food supplements, food, medical preparationsACTIVE—
005Micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and to reared animal species, for medical and veterinary use; micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, anallergic bifidobacterium probiotic bacteria which has beneficial activity on the intestinal microflora of babies; proprietary medicine containing micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, bifidobacterium probiotic bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora such as diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, to be taken orally, in particular in the form of capsules, tablets, solutions, suspensions, granules and granules in dried or freeze-dried form; food supplements, food supplements for medical use containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings; dietary supplements; food supplements containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and reared animal species, not for medical or veterinary use; symbiotic dietary supplements containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria and prebiotic fibres; food supplements for animals, not for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 7, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 7, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 7, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 7, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 4, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 14, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 14, 2025FIMPFINAL DISPOSITION PROCESSED—
Jan 8, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 8, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 8, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 14, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 28, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 28, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2024RFNTREFUSAL PROCESSED BY IB—
Dec 13, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 13, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 6, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2023DOCKASSIGNED TO EXAMINER—
Apr 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 31, 2023SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance